One-year outcome of intravitreal ziv-aflibercept therapy for non-responsive neovascular age-related macular degeneration.

CONCLUSION: IVZ increased the treatment free interval in non-responders but no significant change in visual and anatomic outcomes.
PMID: 28596286 [PubMed - as supplied by publisher]

Source: The British Journal of Ophthalmology - June 8, 2017 Category: Opthalmology Authors: Braimah IZ, Agarwal K, Mansour A, Chhablani J, Ziv-aflibercept Study Group Tags: Br J Ophthalmol Source Type: research